Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 1;13(3):552.
doi: 10.3390/cancers13030552.

Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative Review

Affiliations
Review

Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative Review

Ahmad Chaddad et al. Cancers (Basel). .

Abstract

The management of prostate cancer (PCa) is dependent on biomarkers of biological aggression. This includes an invasive biopsy to facilitate a histopathological assessment of the tumor's grade. This review explores the technical processes of applying magnetic resonance imaging based radiomic models to the evaluation of PCa. By exploring how a deep radiomics approach further optimizes the prediction of a PCa's grade group, it will be clear how this integration of artificial intelligence mitigates existing major technological challenges faced by a traditional radiomic model: image acquisition, small data sets, image processing, labeling/segmentation, informative features, predicting molecular features and incorporating predictive models. Other potential impacts of artificial intelligence on the personalized treatment of PCa will also be discussed. The role of deep radiomics analysis-a deep texture analysis, which extracts features from convolutional neural networks layers, will be highlighted. Existing clinical work and upcoming clinical trials will be reviewed, directing investigators to pertinent future directions in the field. For future progress to result in clinical translation, the field will likely require multi-institutional collaboration in producing prospectively populated and expertly labeled imaging libraries.

Keywords: Gleason score; artificial intelligence; magnetic resonance imaging; prostate cancer; radiogenomics; radiomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the standard radiomics model. (1) Multiparametric MRI (mpMRI) image acquisition. (2) Segmentation: tumor labeling-green/white contour. (3) Imaging features extraction using shape, texture, and/or deep features derived from convolution neural network layers. (4) Clinical, radiomic features, molecular data for statistical analyses, based significance test and classifier models, to identify relevant features for predicting the clinical outcome (e.g., Gleason score).

References

    1. Rawla P. Epidemiology of prostate cancer. World J. Oncol. 2019;10:63–89. doi: 10.14740/wjon1191. - DOI - PMC - PubMed
    1. Fitzmaurice C., Akinyemiju T.F., Lami F.H.A., Alam T., Alizadeh-Navaei R., Allen C., Alsharif U., Alvis-Guzman N., Amini E., Anderson B.O., et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the global burden of disease study. JAMA Oncol. 2018 doi: 10.1001/jamaoncol.2018.2706. - DOI - PMC - PubMed
    1. Hamdy F.C., Donovan J.L., Lane J.A., Mason M., Metcalfe C., Holding P., Davis M., Peters T.J., Turner E.L., Martin R.M., et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N. Engl. J. Med. 2016;375:1415–1424. doi: 10.1056/NEJMoa1606220. - DOI - PubMed
    1. Zapatero A., Guerrero A., Maldonado X., Alvarez A., Segundo C.G.S., Rodríguez M.A.C., Macias V., Olive A.P., Casas F., Boladeras A., et al. High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): A randomised, controlled, phase 3 trial. Lancet Oncol. 2015;16:320–327. doi: 10.1016/S1470-2045(15)70045-8. - DOI - PubMed
    1. Epstein J.I. Prostate cancer grading: A decade after the 2005 modified system. Mod. Pathol. 2018;31:S47–S63. doi: 10.1038/modpathol.2017.133. - DOI - PubMed

LinkOut - more resources